Literature DB >> 2579237

[3H]Batrachotoxinin A 20 alpha-benzoate binding to voltage-sensitive sodium channels: a rapid and quantitative assay for local anesthetic activity in a variety of drugs.

E T McNeal, G A Lewandowski, J W Daly, C R Creveling.   

Abstract

[3H]Batrachotoxinin A benzoate ( [3H]BTX-B) binds with high affinity to sites on voltage-dependent sodium channels in a vesicular preparation from guinea pig cerebral cortex. In this preparation, local anesthetics competitively antagonize the binding of [3H]BTX-B. The potencies of some 40 classical local anesthetics and a variety of catecholamine, histamine, serotonin, adenosine, GABA, glycine, acetylcholine, and calcium antagonists, tranquilizers, antidepressants, barbiturates, anticonvulsants, steroids, vasodilators, antiinflammatories, anticoagulants, analgesics, and other agents have been determined. An excellent correlation with the known local anesthetic activity of many of these agents indicate that antagonism of binding of [3H]BTX-B binding provides a rapid, quantitative, and facile method for the screening and investigation of local anesthetic activity.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2579237     DOI: 10.1021/jm00381a019

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  13 in total

1.  Discovery of diphenyl amine based sodium channel blockers, effective against hNav1.2.

Authors:  Debjani P Hudgens; Catherine Taylor; Timothy W Batts; Manoj K Patel; Milton L Brown
Journal:  Bioorg Med Chem       Date:  2006-10-10       Impact factor: 3.641

Review 2.  Molecular targets versus models for new antiepileptic drug discovery.

Authors:  Michael A Rogawski
Journal:  Epilepsy Res       Date:  2006-01       Impact factor: 3.045

3.  Inhibition by anaesthetics of 14C-guanidinium flux through the voltage-gated sodium channel and the cation channel of the 5-HT3 receptor of N1E-115 neuroblastoma cells.

Authors:  M Barann; M Göthert; K Fink; H Bönisch
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-02       Impact factor: 3.000

4.  Batrachotoxin changes the properties of the muscarinic receptor in rat brain and heart: possible interaction(s) between muscarinic receptors and sodium channels.

Authors:  M Cohen-Armon; Y Kloog; Y I Henis; M Sokolovsky
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

5.  Procaine isothiocyanate: an irreversible inhibitor of the specific binding of [3H]batrachotoxinin-A benzoate to sodium channels.

Authors:  C R Creveling; M E Bell; T R Burke; E Chang; G A Lewandowski-Lovenberg; C H Kim; K C Rice; J W Daly
Journal:  Neurochem Res       Date:  1990-04       Impact factor: 3.996

6.  Effects of some antianginal and vasodilating drugs on sodium influx and on the binding of 3H-batrachotoxinin-A 20-alpha-benzoate and 3H-tetracaine.

Authors:  J Velly; M Grima; G Marciniak; M O Spach; J Schwartz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-02       Impact factor: 3.000

7.  Ligand-based design and synthesis of novel sodium channel blockers from a combined phenytoin-lidocaine pharmacophore.

Authors:  Yuesheng Wang; Paulianda J Jones; Timothy W Batts; Victoria Landry; Manoj K Patel; Milton L Brown
Journal:  Bioorg Med Chem       Date:  2008-10-17       Impact factor: 3.641

8.  Block of human voltage-sensitive Na+ currents in differentiated SH-SY5Y cells by lifarizine.

Authors:  N A Brown; J A Kemp; G R Seabrook
Journal:  Br J Pharmacol       Date:  1994-10       Impact factor: 8.739

9.  Interactions of DPI 201-106, a novel cardiotonic agent, with cardiac calcium channels.

Authors:  P K Siegl; M L Garcia; V F King; A L Scott; G Morgan; G J Kaczorowski
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-12       Impact factor: 3.000

10.  Anti-anginal arylalkylamines and sodium channels: [3H]-batrachotoxinin-A 20-alpha-benzoate and [3H]-tetracaine binding.

Authors:  M Grima; J Schwartz; M O Spach; J Velly
Journal:  Br J Pharmacol       Date:  1986-12       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.